Skip to main content
Clinical Trials/IRCT2013062613783N1
IRCT2013062613783N1
Completed
未知

Determining efficacy of smoke cessation program on quit Rate, immunological response and treatment outcome in new pulmonary tuberculosis patients: a clinical trial

Shahid Beheshti University of Medical Sciences0 sites240 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
tuberculosis.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
240
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • current manufactured cigarette smokers will be diagnosed with active pulmonary TB: either sputum smear\-positive or smear\-negative, based on classification from WHO treatment guidelines; classify under treatment Category I (new TB cases) ; patients of both sexes, aged 18 years and above; speaking the Persian language.
  • Exclusion criteria: having extra pulmonary TB only (involving CNS, pericardium, adrenal etc) ; they have multi\-drug resistant tuberculosis at diagnosis ; they are living with or newly diagnosed with HIV/AIDS ; they are active IV drug abuser ; they are classified as Category II (relapse, treatment failure, and treatment after default) or Category III (chronic TB) ;they fulfill the eligibility criteria, but unwilling to participate in the study or unable to understand the contents of the informed consent form.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials